These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22544299)

  • 21. Biopharmaceutical benchmarks 2018.
    Walsh G
    Nat Biotechnol; 2018 Dec; 36(12):1136-1145. PubMed ID: 30520869
    [No Abstract]   [Full Text] [Related]  

  • 22. Profile: William Haseltine.
    Herrera S
    Nat Biotechnol; 2005 Aug; 23(8):913. PubMed ID: 16082351
    [No Abstract]   [Full Text] [Related]  

  • 23. Profile: Alpheus Bingham.
    Wilan K
    Nat Biotechnol; 2007 Oct; 25(10):1072. PubMed ID: 17921979
    [No Abstract]   [Full Text] [Related]  

  • 24. Profile: Jean-Paul Clozel.
    Schmidt C
    Nat Biotechnol; 2007 Feb; 25(2):155. PubMed ID: 17287737
    [No Abstract]   [Full Text] [Related]  

  • 25. "Extraordinary Measures": Arrowsmith for the NASDAQ era.
    Weissmann G
    FASEB J; 2010 Apr; 24(4):963-7. PubMed ID: 20356907
    [No Abstract]   [Full Text] [Related]  

  • 26. Abe Abuchowski.
    Katsnelson A
    Nat Biotechnol; 2006 Sep; 24(9):1050. PubMed ID: 16964200
    [No Abstract]   [Full Text] [Related]  

  • 27. Lessons from the past. Some members of the biotech class of 1982-83 reflect on the startup experience.
    Middleton A
    Biotechnology (N Y); 1993 Mar; 11(3):S40-3. PubMed ID: 7763434
    [No Abstract]   [Full Text] [Related]  

  • 28. Profile: Una Ryan.
    Schmidt C
    Nat Biotechnol; 2006 Aug; 24(8):881. PubMed ID: 16900115
    [No Abstract]   [Full Text] [Related]  

  • 29. History of modern genetics in Germany.
    Hammar F
    Adv Biochem Eng Biotechnol; 2002; 75():1-29. PubMed ID: 11783839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controversial medical and agri-food biotechnology: a cultivation analysis.
    Bauer MW
    Public Underst Sci; 2002 Apr; 11(2):93-111. PubMed ID: 14621673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An interview with Martin Rosenberg, Ph.D. Interviewed by Vicki Glaser.
    Rosenberg M
    Assay Drug Dev Technol; 2009 Dec; 7(6):537-43. PubMed ID: 20035618
    [No Abstract]   [Full Text] [Related]  

  • 32. Sustainability in the biopharmaceutical industry: Seeking a holistic perspective.
    Lalor F; Fitzpatrick J; Sage C; Byrne E
    Biotechnol Adv; 2019; 37(5):698-707. PubMed ID: 30922993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Remembering Marvin Weinstein (1916-2011).
    Demain AL; Weinstein RN
    J Antibiot (Tokyo); 2012 Jul; 65(7):381-2. PubMed ID: 22836814
    [No Abstract]   [Full Text] [Related]  

  • 34. Growing pains for biopharmaceuticals.
    Ashton G
    Nat Biotechnol; 2001 Apr; 19(4):307-11. PubMed ID: 11283578
    [No Abstract]   [Full Text] [Related]  

  • 35. Profile: Corey Goodman.
    Kling J
    Nat Biotechnol; 2009 Apr; 27(4):308. PubMed ID: 19352358
    [No Abstract]   [Full Text] [Related]  

  • 36. History, Current State, and Emerging Applications of Industrial Biotechnology.
    Schürrle K
    Adv Biochem Eng Biotechnol; 2020; 173():13-51. PubMed ID: 30671594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profile: Jean Deleage.
    Ratner M
    Nat Biotechnol; 2005 Oct; 23(10):1197. PubMed ID: 16211047
    [No Abstract]   [Full Text] [Related]  

  • 38. 30 Years of Biotherapeutics Development-What Have We Learned?
    Ghilardi N; Pappu R; Arron JR; Chan AC
    Annu Rev Immunol; 2020 Apr; 38():249-287. PubMed ID: 32340579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The birth of biotechnology.
    Russo E
    Nature; 2003 Jan; 421(6921):456-7. PubMed ID: 12540923
    [No Abstract]   [Full Text] [Related]  

  • 40. Profile: Thomas Lönngren.
    Louët S
    Nat Biotechnol; 2004 Nov; 22(11):1341. PubMed ID: 15529143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.